Search
for
Sort by
Research 31–60 of 1000+
- Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T‐Cell Lymphoma: A Real‐World Single‐Center Experience
- Topical Janus kinase inhibitors: A review of applications in dermatology
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- The Role of Tofacitinib in the Management of Alopecia Totalis
- S116 Treatment of Concomitant Alopecia Areata and Crohn’s Disease in a Young Child With Tofacitinib: Case Report
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- BH08 Unprovoked pulmonary emboli in a patient with alopecia areata treated with ritlecitinib: a case report
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- Autophagy Stimulation Improves Erythroid Proliferative Capacity in Models of SF3B1 Mutant MDS
- Les Rencontres d’Experts du Psoriasis : des recommandations pour la pratique quotidienne
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- Oral Baricitinib Restores Hair Loss in Alopecia Areata
- Baricitinib: A Review in Severe Alopecia Areata
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials
- 504 A single-center retrospective study evaluating the efficacy of intravenous methylprednisolone pulse therapy for 113 patients with alopecia areata
- Excellent response to tofacitinib treatment in a patient with alopecia universalis
- Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Real‐World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- A Case of Tofacitinib for the Treatment of Resistant Vitiligo and Sustained Repigmentation After Discontinuation
- Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata